Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 53: 742-747, 2007. First published March 1, 2007; 10.1373/clinchem.2006.079012
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2006.079012v1
53/4/742    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (15)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Groener, J. E.M.
Right arrow Articles by Aerts, J. M.F.G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Groener, J. E.M.
Right arrow Articles by Aerts, J. M.F.G.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Pediatric Clinical Chemistry
Right arrow Lipids, Lipoproteins, and Cardiovascular Risk Factors
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2007;53:742-747.)
© 2007 American Association for Clinical Chemistry, Inc.

Automation and Analytical Techniques

HPLC for Simultaneous Quantification of Total Ceramide, Glucosylceramide, and Ceramide Trihexoside Concentrations in Plasma

Johanna E.M. Groener1,a, Ben J.H.M. Poorthuis1, Sijmen Kuiper1, Mariette T.J. Helmond1, Carla E.M. Hollak2 and Johannes M.F.G. Aerts1

Departments of1 Medical Biochemistry and 2 Internal Medicine, University of Amsterdam, Academic Medical Center, Amsterdam, The Netherlands.

aAddress correspondence to this author at: Department of Medical Biochemistry, University of Amsterdam, Academic Medical Center, P.O. Box 22700, 1100 DE Amsterdam, The Netherlands. Fax 31-20-6915519; e-mail j.e.groener{at}amc.uva.nl.

Background: Simple, reproducible assays are needed for the quantification of sphingolipids, ceramide (Cer), and sphingoid bases. We developed an HPLC method for simultaneous quantification of total plasma concentrations of Cer, glucosylceramide (GlcCer), and ceramide trihexoside (CTH).

Methods: After addition of sphinganine as internal calibrator, we extracted lipids from 50 µL plasma. We deacylated Cer and glycosphingolipids by use of microwave-assisted hydrolysis in methanolic NaOH, followed by derivatization of the liberated amino-group with o-phthaldialdehyde. We separated the derivatized sphingoid bases and lysoglycosphingolipids by HPLC on a C18 reversed-phase column with a methanol/water mobile phase (88:12, vol/vol) and quantified them by use of a fluorescence detector at {lambda}ex 340 nm and {lambda}em 435 nm.

Results: Optimal conditions in the Solids/Moisture System SAM-155 microwave oven (CEM Corp.) for the complete deacylation of Cer and neutral glycosphingolipids without decomposition were 60 min at 85% power, fan setting 7. Intra- and interassay CVs were <4% and <14%, respectively, and recovery rates were 87%–113%. The limit of quantification was 2 pmol (0.1 pmol on column), and the method was linear over the interval of 2–200 µL plasma. In samples from 40 healthy individuals, mean (SD) concentrations were 9.0 (2.3) µmol/L for Cer, 6.3 (1.9) µmol/L for GlcCer, and 1.7 (0.5) µmol/L for CTH. Plasma concentrations of GlcCer were higher in Gaucher disease patient samples and of CTH in Fabry disease patient samples.

Conclusions: HPLC enables quantification of total Cer, GlcCer, and CTH in plasma and is useful for the follow-up of patients on therapy for Gaucher or Fabry disease.




The following articles in journals at HighWire Press have cited this article:


Home page
 J. Biol. Chem.Home page
G. H. B. Maegawa, M. B. Tropak, J. D. Buttner, B. A. Rigat, M. Fuller, D. Pandit, L. Tang, G. J. Kornhaber, Y. Hamuro, J. T. R. Clarke, et al.
Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease
J. Biol. Chem., August 28, 2009; 284(35): 23502 - 23516.
[Abstract] [Full Text] [PDF]

Home page
 GlycobiologyHome page
K. Zama, Y. Hayashi, S. Ito, Y. Hirabayashi, T. Inoue, K. Ohno, N. Okino, and M. Ito
Simultaneous quantification of glucosylceramide and galactosylceramide by normal-phase HPLC using O-phtalaldehyde derivatives prepared with sphingolipid ceramide N-deacylase
Glycobiology, July 1, 2009; 19(7): 767 - 775.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
N. Bijl, S. Scheij, S. Houten, R. G. Boot, A. K. Groen, and J. M. F. G. Aerts
The Glucosylceramide Synthase Inhibitor N-(5-Adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin Induces Sterol Regulatory Element-Binding Protein-Regulated Gene Expression and Cholesterol Synthesis in HepG2 Cells
J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 849 - 855.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. M. Aerts, J. E. Groener, S. Kuiper, W. E. Donker-Koopman, A. Strijland, R. Ottenhoff, C. van Roomen, M. Mirzaian, F. A. Wijburg, G. E. Linthorst, et al.
Elevated globotriaosylsphingosine is a hallmark of Fabry disease
PNAS, February 26, 2008; 105(8): 2812 - 2817.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. R. Soeters, H. P. Sauerwein, J. E. Groener, J. M. Aerts, M. T. Ackermans, J. F. C. Glatz, E. Fliers, and M. J. Serlie
Gender-Related Differences in the Metabolic Response to Fasting
J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3646 - 3652.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Association for Clinical Chemistry.